ARYA Sciences Acquisition Corp IV (ARYD) to Combine with Caritas Therapeutics in $242M Deal

ARYA IV (NASDAQ:ARYD) has entered into a definitive agreement to combine with Amicus (NASDAQ:FOLD)’s gene therapy business to create a separate entity called Caritas Therapeutics with an enterprise value of $242.3 million. This division of Philadelphia-based Amicus is developing a series of gene therapies to treat rare genetic disorders that primarily afflict children and carry
Read More